fredag 27 april 2018

One crucial factor we often take for granted

In our 40 years, there is one lesson Swecare learned early, and which has been proven time and time again: successfully launching a Swedish healthcare company in a new market requires solid collaboration with a local partner. One with intimate knowledge of the local healthcare systems, long-term relationships with the key players within it, and a determination to do good. As a celebrity recently claimed – healthcare is complicated. Even those working in other industries, including defense, would agree that nowhere does local values, politics, culture, economic means have more impact than in healthcare. Projections of GDP growth, investment figures, risk assessments, population dividend and other macro figures are not enough to determine whether a product or service from within the Swedish healthcare and life science sector will be successful in a new market. Ours is a traditional sector by definition – nothing is as sacred as saving lives. Introducing new solutions even within our own borders is a challenge, doing so in countries which do not share our language, culture, social structure, even more so. Swecare realised early that our secret weapon is, and despite the advent of AI will remain for some time, our partners around the world - partners who have a stake in our success: who understand the way doctors work, hospitals purchase, politicians fund, and patient seek care.
Swedish Medtech, Swecare, and InnovatioCuris
representatives signing the MoU at Vitalis 2018 in Gothenburg

This week marked another milestone in Swecare's work within the EU-funded Central Baltic Health Access project. While we served as 'local' coaches for the companies within this Swedish Medtech-led project, the success of the program was very much dependent on our 'target market' coaches. In March we signed a Memorandum of Understanding with Uganda Healthcare Federation strengthening our commitment to work together in order to support more companies in entering the Ugandan Market. And on Tuesday this week Swecare signed an MoU with Sachin Gaur of InnovatioCuris at Vitalis 2018, pledging:
  • exchange of information
  • promotion of opportunities
  • initial contact and consultation
  • networking services
Sachin has proven to be an incredible partner, with InnovatioCuris providing the companies that traveled to India under CBHA with invaluable support. He is an expert on cyber security and innovations in healthcare management. Together with his CEO Dr VK Singh, they have turned InnovatioCuris into one of the few leading consultancies focussing solely in healthcare and life sciences in India. We hope that this project is once of many more collaborations to come.

Tallinn Science Park Technopol, Uganda Healthcare Federation,
and Swecare representatives signing the MoU with
Swedish and Ugandan Ministries of Health as witness in Kampala
CB Health Access program was initiated in 2016 between Estonian, Finnish, Latvian and Swedish technology organizations to support entrepreneurship in health technologies. The program facilitates the entry of Estonian, Latvian, Swedish and Finnish health tech companies to distant markets – South Korea, USA, India and Uganda. CB Health Access provides the companies with an introduction of the target market, individual coaching both from the home country and from target market experts, market information, business missions, and identifying and contacting potential partners, and business missions. The program has a strong focus for the companies to achieve sales in the chosen market. The program is financed by Central Baltic Interreg Program.

For more information on the CB Health Access program see and visit Swecare Blog.

Inga kommentarer:

Skicka en kommentar